FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV

NCT02599246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2017-02-01

No results posted yet for this study

Summary

The purpose of this study is to compare pharyngeal FiO2 in day time with nasal normobaric O2 with inhaled FiO2 in the night time with home care ventilator NIV at the same O2 flow.

Conditions

  • COPD
  • Home Care
  • Oxygen Therapy

Sponsors & Collaborators

  • Breas Medical S.A.R.L.

    lead INDUSTRY

Principal Investigators

  • Philippe GOUTORBE, MD · Military teaching hospital Ste ANNE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-17
Primary Completion
2016-02-22
Completion
2016-02-24

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02599246 on ClinicalTrials.gov